Salute e Benessere

Exploring Myasthenia Gravis Disease with DLI's Drug Insights, Clinical Trial…

Timely MG prognosis is crucial to ensure the well being of a patient. This happens only after the disease is diagnosed timely. Proper MG management necessitates effective diagnostic and treatment entities. Industry participants are striving to bring about the much-needed transformation in this vertical. Disease Landscape Insights has been helping them with MG research, treatment gaps identification, product pipeline analysis, drug development, regulatory consulting, clinical trial feasibility…
PR Newswire
10/10/2023

Implantica's RefluxStop™ made a substantial impact at the American Foregut…

The moderator and panel included: The moderator and panel included: "RefluxStop surgery is an excellent option for treating GERD because it gives consistently good results," said Dr. Zehetner"It's also an option for patients with ineffective esophageal motility (affecting food transportation) as well as patients with large hiatal hernias." He has performed >90 RefluxStop procedures and presented his excellent results in a scientific poster. Prof.Schoppmannexplained…
PR Newswire
10/10/2023

AlphaBiolabs: Leading testing laboratory launches the most powerful DNA…

But although all DNA relationship tests work in the same way, they are not all of the same quality. But although all DNA relationship tests work in the same way, they are not all of the same quality. The AlphaBiolabs standard DNA relationship test is already market-leading, as it analyses 25 DNA markers (loci), whereas the industry standard only analyses 16-21 markers. What makes AlphaBiolabs unique is that it can now analyse up to 45 DNA markers. This means that more genetic material is...
PR Newswire
10/10/2023

Philips announces new interoperability capabilities that offer a comprehensive…

Interoperability of Philips Capsule Medical Device Information Platform (MDIP) with Philips Patient Information Center iX (PIC iX) includes streaming, vendor-neutral data to support care delivery and collaborationAmsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced the interoperability of Philips Capsule Medical Device Information Platform (MDIP) with Philips Patient Information Center iX (PIC iX),...
Nasdaq GlobeNewswire
10/10/2023

Redefining Hepatitis B Disease Management with DLI's drug insights, pipeline…

Price & Market Access Price & Market Access Players are making extensive efforts to develop efficient hepatitis b vaccine and hepatitis b medications for the patients. They are participating in R&D activities with help from leading healthcare consulting services provider, Disease Landscape Insights. This health consultant has been supporting them in drug development, treatment gaps identification, clinical trial feasibility analysis, drug launch strategies, price and market access...
PR Newswire
10/10/2023

Navigating through Multiple Sclerosis Disease Landscape through DLI's Clinical…

The playing operating in this landscape are emphasizing on strengthening their industry position by bring about the much-needed transformation in the MS management vertical. DLI has been a support system to these players when it comes to treatment gaps identification, MS clinical trials, clinical trial feasibility analysis, product portfolio extension, along with price and market access decisions. By procuring its healthcare consulting services, the industry participants can also get their hands…
PR Newswire
10/10/2023

Pheon Therapeutics Appoints Oncology Expert Arvin Yang, MD, PhD as Chief Medical…

Cyrus Mozayeni, Chief Executive Officer of Pheon Therapeutics, said: "As a seasoned Chief Medical Officer, Dr. Yang's extensive industry and leadership experience position him perfectly to take Pheon into the next stage of our growth as a clinical-stage company. His deep knowledge of oncology clinical development will be invaluable as we advance our first-in-class ADCs for the treatment of solid tumors." Cyrus Mozayeni , Chief Executive Officer of Pheon Therapeutics, said : "As a…
PR Newswire
10/10/2023

Mission Therapeutics to Present at Michael J. Fox Foundation's 15th Annual…

As the world's largest nonprofit funder of Parkinson's research, The Michael J. Fox Foundation (MJFF) is dedicated to accelerating a cure for Parkinson's Disease and improved therapies for those living with the condition today. The annual Michael J. Fox Foundation's Parkinson's Disease Therapeutics Conference brings together 300 research and business development professionals from both academia and industry and showcases the most exciting and innovative research from MJFF's research portfolio…
PR Newswire
10/10/2023

Frost & Sullivan Launches the EmpowerHer Program to Bridge the Growth Gap in…

The growth gap in women's health is a multifaceted challenge rooted in three critical areas: a lack of comprehensive clinical research, limited access to healthcare, and insufficient funding for women's health technology. This formidable gap poses a significant obstacle to delivering effective care to women worldwide. The growth gap in women's health is a multifaceted challenge rooted in three critical areas:a lack of comprehensive clinical research, limited access to healthcare, and...
PR Newswire
10/10/2023

Elevating Autoimmune Disease Market Understanding with DLI's Research Expertise…

Disease Landscape Insights has been offering healthcare consulting services to the players operating in this vertical. From drug development, clinical trial management, and treatment gaps identification to the formulation of drug launch strategies, DLI has been assisting them through all such complicated phases. Disease Landscape Insightshas been offering healthcare consulting services to the players operating in this vertical. From drug development, clinical trial management, and treatment...
PR Newswire
10/10/2023

Oncotech AI-powered diagnostic mobile cancer and diabetes screening app…

Using the app, physicians can use their own smartphone devices to photograph the iris of their patients and upload images to the Oncotech server. The Oncotech AI diagnostic and machine learning system then sends the results back to the clinician within just 45 seconds. Using the app, physicians can use their own smartphone devices to photograph the iris of their patients and upload images to the Oncotech server. The Oncotech AI diagnostic and machine learning system then sends the results...
PR Newswire
10/10/2023

XNK Therapeutics receives funding from Sweden's innovation agency Vinnova

About XNK Therapeutics AB About XNK Therapeutics AB XNK Therapeutics is a clinical stage immunotherapy company focused on bringing new and more effective treatments to cancer patients. The company is at the forefront of autologous NK cell-based cell therapy development with a proprietary technology platform and a pipeline spanning both hematological malignancies and solid tumor indications. The most advanced product, evencaleucel, is in phase II studies in combination with the CD38...
PR Newswire
10/10/2023

Novozymes announce the Executive Leadership Team and organizational structure…

October 10, 2023 Please see attachment. Contact informationInvestor RelationsAnders Mohr Christensen +45 2515 2364dkamc@chr-hansen.comPress RelationsSanne Seyer-Hansen +45 6038 6207dksash@chr-hansen.comAttachment 2023_Novozymes announce the Executive Leadership Team and organizational structure
Nasdaq GlobeNewswire
10/10/2023

Empowering Addison's Disease Players with DLI's Drug insights, clinical trial…

Price and Market Access Price and Market Access Industry players are making extensive efforts to develop effective Addison's management solutions. They are engaged in continuous R&D activities with an aim to improve the quality of life of the patients affected with autoimmune adrenalitis. DiseaseLandscape Insights has been a support system to these players in their aim to efficiently deal with Addison's crisis. It has been helping them with drug development, treatment gaps...
PR Newswire
10/10/2023

Alimentiv and Satisfai Health Announce Commercial Availability of Highly…

Certai will be made available in Alimentiv's multi-modal imaging platform, Notō, offering a unique end-to-end solution supporting image review and centralized scoring. "The technical integration of Satisfai's products into Alimentiv's software provides a foundation for the future advanced capabilities in digital biomarker identification, precision medicine, and companion diagnostics. We are very excited to bring these advancements in digital analysis into our portfolio," said Jeff…
PR Newswire
10/10/2023

Mydecine Innovations Group Announces Admission to Trading on the AQSE Growth…

Mydecine Innovations Group, Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE: MYIG) (OTC: MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD, announces that it has completed its admission to the Access segment of the AQSE Growth Market (“ AQSE ”) and trading will commence at 8:00 A.M. GMT on Tuesday, 10 October 2023 (" Admission ")…
Nasdaq GlobeNewswire
10/10/2023

Executive Leadership Team and organizational structure announced for the future…

Read the full announcement in PDF Attachment 2023_57_Executive_Leadership_Team
Nasdaq GlobeNewswire
10/10/2023

AstriVax Strengthens Leadership Team by Welcoming Chief Development Officer…

Dr. Mathieu Peeters brings an extensive clinical vaccine development track record from his senior roles at GSK Vaccines.Barbara Freitag joins AstriVax as an accomplished CFO in the biotech sector.These appointments further strengthen AstriVax's company building towards a clinical stage company. Leuven, Belgium, October 10, 2023– AstriVax is pleased to announce that Dr. Mathieu Peeters and Barbara Freitag have joined the company's leadership team as Chief Development Officer and...
Nasdaq GlobeNewswire
10/10/2023

dsm-firmenich achieves regulatory clearance in China for two HMO ingredients for…

Data on concentrations of HMOs found in human breast milk globally were taken into consideration by the China National Center for Food Safety Risk Assessment (CFSA) to set the approved maximum usage level. Currently, 2'-FL and LNnT are the only HMO ingredients approved in the Chinese market. Data on concentrations of HMOs found in human breast milk globally were taken into consideration by the China National Center for Food Safety Risk Assessment (CFSA) to set the approved maximum usage level...
PR Newswire
10/10/2023

Roche's Vabysmo maintained vision improvements with extended treatment intervals…

Vabysmo showed robust and sustained retinal drying up to 72 weeks and a safety profile consistent with previous studiesRegulatory applications for Vabysmo in RVO are under review by health authorities around the world; if approved, RVO would be the third indication in addition to nAMD and DMEVabysmo is the first and only treatment that targets and inhibits two signalling pathways linked to a number of vision-threatening retinal conditionsBasel, 10 October 2023 - Roche (SIX: RO,...
Nasdaq GlobeNewswire
10/10/2023

Mental Health is the Foundation for Learning

Today, 224 million children and adolescents – and their teachers – live through experiences that create chronic anxiety, depression and various degrees of trauma affecting their mental health. They see and live through the most excruciating pain imaginable. The soul-shattering pain of executions of family members, sudden loss of parents and siblings, all while their homes and schools are bombed and burnt down. They live with a daily fear of sexual violence, gender-based violence, trafficking…
PR Newswire
10/10/2023

The Evolving Market Dynamics of Factor-based Bleeding Disorders: Hemophilia A…

DelveInsight has recently released a series of epidemiology-based market reports focusing on factor-based bleeding disorders including Hemophilia A, Hemophilia B, and Von Willebrand Disease. These reports include a comprehensive understanding of current treatment practices, emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032 segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and…
PR Newswire
09/10/2023

PHAXIAM Therapeutics announces high coverage performance of its two…

PHAXIAM Therapeutics announces high coverage performance of its two anti- Staphylococcus aureusphages over clinical strains Data from PHAXIAM's phagogram, first CE-marked Phage Susceptibility Test (PST), showed 98% response rate over 105 clinical S. aureus strains Lyon (France) et Cambridge (MA, US), October 9, 2023 at 10:05pm CEST – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM),today announced a very high spectrum of activity of its anti- S. aureus(PP1493 and PP1815)...
Nasdaq GlobeNewswire
09/10/2023

MDxHealth Reports Preliminary Q3-2023 Revenues

NEWS RELEASE – INSIDE AND REGULATED INFORMATION 9 OCTOBER 2023, 4PM ET / 22:00 CET MDxHealth Reports Preliminary Q3-2023 Revenues IRVINE, CA, and HERSTAL, BELGIUM– October 9, 2023 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today reported preliminary third quarter 2023 revenues, units, and cash position.For the third quarter ended September 30, 2023, the Company expects to report revenues of approximately $19.3 million,...
Nasdaq GlobeNewswire
09/10/2023
Altri  Comunicati